Current Problems in Cancer RSS feed: Current Issue. Each bimonthly issue of Current Problems in Cancer presents a single-topic, in-depth discussion, usually focused on the integrated management of a particular type of cancer or on a problem faced in a wide variety of malignancies. Issues may explore a particular category of drugs, an emerging interventional technique, or rehabilitation/reconstruction. Extensive bibliographies allow readers to easily locate additional information on related topics. Current Problems in Cancer serves the wide spectrum of physicians who treat patients with neoplastic disease. 2012 Topics , Volume 36 Multidisciplinary Management of Intracranial Ependymoma Michael D. Chan, Kevin P. McMullen Isolated Hepatic Perfusion David Bartlett, Amer Zureikat Small Cell Lung Cancer Benjamin Movsas Working with SEER Data: Opportunities and Cautions James Yu Management of the Axilla in Breast Cancer Elin Sigurdson Cancer of the Oropharynx Beth Beadle, Chris Holsinger http://www.cpcancer.com/?rss=yesElsevier Inc.en © 2012 Published by Elsevier Inc. All rights reserved. Current Problems in Cancer0147-0272362March 2012 © 2012 Published by Elsevier Inc. All rights reserved. healthpermissions@elsevier.comhttp://www.cpcancer.com/article/PIIS0147027212000268/abstract?rss=yesTitle Page10.1016/S0147-0272(12)00026-8Current Problems in Cancer 36, 2 (2012)2012-03-01Current Problems in Cancer2012-03-01362S0147-0272(11)X0009-02121http://www.cpcancer.com/article/PIIS0147027212000232/abstract?rss=yesInformation for Readers10.1016/S0147-0272(12)00023-2Current Problems in Cancer 36, 2 (2012)2012-03-01Current Problems in Cancer2012-03-01362S0147-0272(11)X0009-02222http://www.cpcancer.com/article/PIIS0147027212000244/abstract?rss=yesTable of Contents10.1016/S0147-0272(12)00024-4Current Problems in Cancer 36, 2 (2012)2012-03-01Current Problems in Cancer2012-03-01362S0147-0272(11)X0009-02324http://www.cpcancer.com/article/PIIS0147027212000256/abstract?rss=yesAuthor Bio Sketch10.1016/S0147-0272(12)00025-6Current Problems in Cancer 36, 2 (2012)2012-03-01Current Problems in Cancer2012-03-01362S0147-0272(11)X0009-02525http://www.cpcancer.com/article/PIIS0147027212000207/abstract?rss=yesThe concept of isolated hepatic perfusion (IHP) for liver metastases represents a new paradigm now, the excellent clinical outcomes associated with IHP for resectable liver metastases may be extended to patients undergoing IHP for unresectable liver metastases. The ability to harness the benefits of high-dose regional cytotoxic therapy in well selected patients, while protecting the patient from the morbidity of systemic exposure, is an inspiring leap forward for those suffering the burden of cancer treatment.ForewordKevin P. McMullen10.1016/j.currproblcancer.2012.02.001Current Problems in Cancer 36, 2 (2012)2012-03-01Current Problems in Cancer2012-03-01362S0147-0272(11)X0009-02626http://www.cpcancer.com/article/PIIS0147027211001401/abstract?rss=yesDevelopment of liver metastases represents a significant clinical challenge in the treatment of cancer. Systemic chemotherapy is the traditional treatment for metastatic disease and, although associated with good initial response rates particularly in the first line setting, survival remains poor in the absence of surgical intervention and after failure of initial systemic therapy. In patients with isolated liver metastasis, surgical resection offers the best hope for long-term survival; however, a large number of patients present with unresectable disease. For patients not eligible for surgical intervention, because of either the unavailability or the failure of initial systemic therapy, regional therapy may offer the potential for improved response rates and better long-term outcomes.Isolated Hepatic Perfusion for the Treatment of Liver MetastasesBrian A. Boone, David L. Bartlett, Amer H. Zureikat10.1016/j.currproblcancer.2011.12.001Current Problems in Cancer 36, 2 (2012)2012-03-01Current Problems in Cancer2012-03-01362S0147-0272(11)X0009-02776